Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Postmarketing Surveillance Will Report To Deputy Galson Under CDER Reorg.

May 21 2001

• By The Pink Sheet

Related Content

FDA Standardized NDA Review Format Includes Gender Analysis

Apr 30 2001

CDER Deputy Galson Brings Risk Management Experience To FDA Surveillance

Apr 02 2001

Priority Review Criteria Reassessment Called For In FDA Rezulin Report

Dec 04 2000

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window